RANI
Income statement / Annual
Last year (2023), Rani Therapeutics Holdings, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Rani Therapeutics Holdings, Inc.'s net income was -$33.97 M.
See Rani Therapeutics Holdings, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$2.72 M
|
$462,000.00
|
$979,000.00
|
| Cost of Revenue |
$822,000.00 |
$1.31 M |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$822,000.00 |
-$1.31 M |
$2.72 M |
$462,000.00 |
$979,000.00 |
| Gross Profit Ratio |
0 |
0 |
1 |
1 |
1 |
| Research and Development
Expenses |
$39.62 M
|
$36.61 M
|
$26.48 M
|
$12.04 M
|
$24.58 M
|
| General & Administrative
Expenses |
$26.48 M
|
$26.84 M
|
$27.83 M
|
$4.96 M
|
$3.47 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$26.48 M
|
$26.84 M
|
$27.83 M
|
$4.96 M
|
$3.47 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$66.10 M |
$63.45 M |
$54.32 M |
$17.01 M |
$28.04 M |
| Cost And Expenses |
$66.10 M |
$63.45 M |
$54.32 M |
$17.01 M |
$28.04 M |
| Interest Income |
$3.30 M |
$1.25 M |
$89,000.00 |
$63,000.00 |
$423,000.00 |
| Interest Expense |
$5.09 M |
$1.07 M |
$466,000.00 |
$124,000.00 |
$10,000.00 |
| Depreciation &
Amortization |
$822,000.00
|
$1.31 M
|
$497,000.00
|
$589,000.00
|
$564,000.00
|
| EBITDA |
-$65.28 M
|
-$60.89 M
|
-$52.08 M
|
-$15.96 M
|
-$26.01 M
|
| EBITDA Ratio |
0 |
0 |
-18.96 |
-34.4 |
-26.64 |
| Operating Income Ratio
|
0
|
0
|
-18.99
|
-35.81
|
-27.65
|
| Total Other
Income/Expenses Net |
-$1.78 M
|
$177,000.00
|
-$1.45 M
|
-$124,000.00
|
$478,000.00
|
| Income Before Tax |
-$67.88 M |
-$63.27 M |
-$53.05 M |
-$16.67 M |
-$26.59 M |
| Income Before Tax Ratio
|
0
|
0
|
-19.52
|
-36.08
|
-27.16
|
| Income Tax Expense |
$0.00 |
$70,000.00 |
$41,000.00 |
$35,000.00 |
$10,000.00 |
| Net Income |
-$33.97 M |
-$63.34 M |
-$53.09 M |
-$16.70 M |
-$26.60 M |
| Net Income Ratio |
0 |
0 |
-19.54 |
-36.15 |
-27.17 |
| EPS |
-1.33 |
-2.66 |
-2.69 |
-0.85 |
-1.35 |
| EPS Diluted |
-1.33 |
-2.66 |
-2.69 |
-0.85 |
-1.35 |
| Weighted Average Shares
Out |
$25.51 M
|
$23.82 M
|
$19.71 M
|
$19.74 M
|
$19.74 M
|
| Weighted Average Shares
Out Diluted |
$25.51 M
|
$23.82 M
|
$19.71 M
|
$19.74 M
|
$19.74 M
|
| Link |
|
|
|
|
|
